The short answer
Aesthetic patient acquisition in Japan must handle a long consideration journey and strict medical advertising rules at once. Trust signals and compliant expression drive conversion.
Patients go through extended pre-procedure search, reviews, and consultation. Design informational content and a consultation-booking path in stages.
Medical advertising restricts efficacy guarantees, comparative superiority, before/after imagery, testimonials, and omitted risk disclosure under the Medical Care Act and its guidelines. Expression review beforehand is essential.
Final responsibility for expression rests with the medical institution (client). RIVACTA reviews expression before spend and designs compliant trust signals.